在PRRT后的长期毒性:神话还是现实
Richard P Baum1,2, Xin Fan3,4,5,6, Vivianne Jakobsson3,4
1CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
Theranostics
|January 3, 2024
概括
对神经内分泌新生瘤 (NENs) 的受体放射性核酸治疗 (PRRT) 在一项长达18年的大型研究中显示,损伤的风险最小. 在PRRT期间适当的脏保护似乎可以防止显著的毒性,使其成为安全的治疗选择.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 受体放射性核素疗法 (PRRT) 的首要问题是毒性.
- 神经内分泌新生瘤 (NENs) 经常用PRRT治疗,因此需要仔细评估安全性.
- 在NEN患者中,关于PRRT诱导的毒性的长期数据对于治疗规划至关重要.
研究的目的:
- 为了评估长期的毒性风险在一个大队伍的NEN患者治疗PRRT超过18年.
- 为了确定影响PRRT后功能变化的因素.
- 评估脏保护策略在缓解PRRT相关脏损伤方面的有效性.
主要方法:
- 对1361名接受1-10周期PRRT (基于Y) 的NEN患者进行了前性分析和前性文档.
- 在随访前和随访期间进行全面的功能监测 (血清肌素,BUN,cGFR,电解质).
- 使用CTCAE v.5.0分级的不良事件,每6个月重新进行一次.
主要成果:
- 在1281名随访患者中,只有小幅增加3/4级功能衰竭 (0.2%至0.7%).
- 平均肌素水平在治疗后略有增加.
- 年龄,循环数,放射性核素类型 (风险更高的90%) 和随访时间是影响毒性的因素.
结论:
- 当与脏保护一起使用PRRT时,在NEN患者中显示出长期毒性风险较低.
- 该研究表明,如果采取适当的保护措施,与PRRT相关的显著毒性并不常见.
- 个性化治疗方法和仔细的患者选择是安全的PRRT管理的关键.
相关概念视频
Radiological Investigation III: Pulmonary Angiogram and PET Scan
93
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
93
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
165
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
165
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K


